Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Chicken feather growth involves specific genes and shares similarities with hair development.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Individualized treatment and psychological support are crucial for alopecia.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Using neurohormones to control keratin can lead to new skin disease treatments.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.